INSIGHTS ON QUALITY CONTROL

• Using Human-Centered Engineering To Improve HPLC Solvent Handling

  Real-world HPLC workflows show how closed-system solvent handling can address contamination, downtime, and waste across laboratory settings.

• Tackling Residual DNA Testing In Biotherapy Manufacturing

  Controlling residual host cell DNA is critical for the safety and efficacy of biotherapeutics. Learn about robust, highly sensitive analytical methods for effective DNA clearance and process control.

• The Seamless Path To Market: End-To-End CDMOs As Your Strategic Ally Douglas CDMO

  Partner with an experienced end-to-end CDMO to streamline development, reduce risk, and accelerate your drug’s path to market in today’s complex and competitive pharmaceutical landscape.

• Quality By Design In The Pharmaceutical Industry

  Real-time release and digital quality management, powered by PAT, are driving efficiency and compliance, reshaping how manufacturers achieve speed, consistency, and competitive advantage.

• Evaluation Of Novel Process Indicators For Hydrogen Peroxide Decontamination

  6/30/2026

  Immediate, quantifiable verification replaces seven-day incubation periods. Discover how enzyme-based indicators optimize hydrogen peroxide decontamination.

• A CDMO's Take On Psychedelic Formulation

  1/26/2026

  Psychedelics show therapeutic promise, but face major formulation and regulatory hurdles. Advances in delivery and neuroscience may unlock new mental‑health treatments.

• Alcami Capabilities Update October 2026: Analytical And Lab Services

  11/3/2026

  Learn how rigorous microbial challenge programs are designed and executed, with practical lessons for overcoming challenges and demonstrating microbiological safety.

• Controlling Nitrosamine Risk In Drug Products: Detection, Formation, And Control Strategies

  7/31/2026

  Bioprocess control relies on clear insight into cell health. Automated tracking cuts risk, saves time, boosts yield, and helps scale up fast to ensure smooth, top quality batch production runs daily.

• Understanding cGMPs For Phase 1 Investigational Drugs

  8/15/2025

  Learn how a structured, risk-based approach to early-phase manufacturing can help streamline processes, reduce costs, and accelerate the path to first-in-human trials while meeting FDA cGMP guidelines.